Cancer Care – Pathway International

Dr Yogesh Kulkarni: Gynecological cancer diagnoses, Treatment, and Prevention

Pathway International — Sun, 17 Jan 2021 13:58:11 +0000

Learn more as Dr. Yogesh Kulkarni talks about Gynecological cancers, diagnosis and treatment, in order to take precautions, make use of the technologies and facilities available for full control of your health

If you have questions, talk directly via Tele-Medicine Conference call/video Call with our Specialist doctors around the world regarding your condition, your health status, and any medical cases, kindly send us a message or book an appointment. If you have questions, talk directly via Tele-Medicine Conference call/video Call with our Specialist doctors around the world regarding your condition, your health status, and any medical cases, kindly send us a message or book an appointment.

[contact-form-7]

Or alternatively, give one of our dedicated case managers a call at +254 733 994 368 or email us at wecare@pathway.international

Pathway International: Providing Global Healthcare Solutions.

The post Dr Yogesh Kulkarni: Gynecological cancer diagnoses, Treatment, and Prevention appeared first on Pathway International.

Dr. S. Hukku – BLK Super Speciality Hospital

Pathway International — Tue, 21 May 2019 12:30:58 +0000

Chairman & Sr. Consultant
Radiation Oncology

Qualification

MBBS (Dr SN Medical College, Jodhpur)
MD (PGI, Chandigarh)

Experience

Previous Assignments
Assistant Professor: Gujarat Cancer & Research Institute: Ahmedabad
Chief, Radiation Oncology: Oswal Cancer Foundation: Ludhiana
Additional Professor: Sanjay Gandhi Post Graduate Institute: Lucknow
Chief Radiation Oncology: Rajiv Gandhi Cancer Institute: New Delhi
Senior Consultant & Coordinator: Indraprastha Apollo Hospital: New Delhi

Fellowships

International Union Against Cancer (UICC) Fellowship: Cookridge Hospital: Leeds UK
Japan International Cooperation Fellowship: Nagoya University: Nagoya Japan
NargisDutt Fellowship: New York Memorial Hospital of Queens : New York USA
British Council Fellowship: St. Bartholomews’ Hospital: London UK

Speciality Interest

Image Guided Radiotherapy (IGRT), Head & Neck Cancer, Brain Tumors, Breast Cancer

Awards and Achievements

President, Association of Radiation Oncologists of India (AROI) 2010-2012
Member International Advisory Group: International Journal of Radiation Oncology Biology & Physics: Journal of American Association for Radiation Oncology (ASTRO)
Expert: International Atomic Energy Agency (IAEA): Vienna Austria
Dr PK Haldar Oration 2013
Dr GN Agarwal Oration 2010
First to initiate stereotactic radiosurgery and stereotactic radiotherapy (SRS/SRT) in India in 1996
First to initiate Intensity Modulated Radiotherapy (IMRT) in North India in 2002

Membership

Association of Radiation Oncologists of India (AROI)
American Association for Radiation Oncology (ASTRO)
European Society of Therapeutic Radiology & Oncology (ESTRO)

Publications Editor:

Proceedings of the X International Conference on the use of Computers (X ICCR) 1990 Over 40 publications in National and International Journals Book Chapters: 2

Observership

Memorial Sloan Kettering Cancer Center: New York USA
MD Anderson Cancer Center: Houston USA
Karolinska Institute: Stockholm Sweden
National Cancer Institute: Tokyo Japan
Christie Hospital &Holt Radium Institute: Manchester UK
Netherlands Cancer Institute (NKI): Amsterdam Netherlands
Institute Gustave Roussy: Paris France
Charite Hospital: Berlin Germany
University of Utrecht: Utrecht Netherlands
Cancer Center: Graz Austria
University Hospital: Uppsala Sweden
University of Pittsburgh: Pittsburgh USA

The post Dr. S. Hukku – BLK Super Speciality Hospital appeared first on Pathway International.

Dr. Devender Sharma – Medanta The Medicity

Pathway International — Tue, 21 May 2019 12:25:02 +0000

Associate Consultant, Medanta – The Medicity, Gurugram

SPECIALITY: Oncologist

EXPERIENCE: 11 Years

LANGUAGE: English, Hindi, Arabic, Russian & More

LOCATION: Gurugram

About Dr. Devender Sharma

Dr. Devender Sharma is a medical oncologist with 11 years of experience. He currently works at Medanta-The Medcity with 11 years of experience. He has a Fellowship in Advanced Laparoscopic Surgery from Indian Association of Gastrointestinal Endo-Surgeons, New Delhi, India.

Treatments Performed By Dr. Devender Sharma

Cancer Care

Practice At

Medanta – The Medicity

Sector 38, Gurugram, Haryana 122018

Educational Background

MS – General Surgery ,PGIMS Medical College, Rohtak, 2003
Fellowship – Advanced Laparoscopic Surgery ,Indian Association of Gastrointestinal Endo-Surgeons, New Delhi, India, 2017
MS – General Surgery ,PGIMS Medical College, Rohtak, 2003
MBBS ,PGIMS Medical College, Rohtak

The post Dr. Devender Sharma – Medanta The Medicity appeared first on Pathway International.

Dr. Vinod Raina – Fortis Memorial Research Institute

Pathway International — Fri, 17 May 2019 08:15:22 +0000

Director & HOD
Fortis Memorial Research Institute, Gurugram
Medical Oncology

Dr. Vinod Raina is one of India’s foremost Medical Oncologist more than 23 years experience in field of Medical Oncology. He perform approximately 600 transplants for various cancers, the largest in India in the last 20 years. This includes about 250 allotransplants. He Transplants Performed first high dose chemotherapy and peripheral blood stem cell transplant in India. Have considerable research experience, Principal investigator of approximately 50 projects in AIIMS, the largest number. Co-Founder of INDOX Network, and a very successful and popular network.

Work Experience:

Working at FMRI as Head of Department & Director of Medical Oncology and Haematology since April 2013
Professor of Medical Oncology at AIIMS 2001-2013
Head Medical Oncology Department at AIIMS April 2007-2013
Head Cancer Center, Royal Hospital, Muscat, Oman: 2 years and 4 months (2001-2004)
Conducted DM course in Medical Oncology for the last 15 years, have trained about 60 DM students, these students are holding consultant positions at important places in India and abroad
Transplants; Performed first high dose chemotherapy and peripheral blood stem cell transplant in India in 1994, till now have personally performed approximately 250 transplants including approximately 70 allotransplants for various cancers
Hon Research Fellow of Oxford University for 5 years (2005-1010)
Headed Delhi Cancer Registry at AIIMS for 5 years. (2005-2010)
Headed Record Section of IRCH AIIMS for 3 years.
Associate Editor of Annals of Oncology 2008-2011

Speciality Interests:

All adult cancers with special interest in Breast, Lung Cancer, Lymphomas, Acute and Chronic Leukemias, Bone marrow and Stem Cell transplants and GI cancer s etc.

Awards and Honours:

Has received many national and international awards

Research Experience:

Principal investigator of approximately 50 projects in AIIMS, the largest number.
Received research funding from Oxford University, University of London, National Cancer Institute USA, DBT, and ICMR and various drug trial sponsors.

Qualification:

MBBS

Main Speciality:

Medical Oncology

The post Dr. Vinod Raina – Fortis Memorial Research Institute appeared first on Pathway International.

Dr. Hari Goyal – Artemis Hospital

Pathway International — Fri, 17 May 2019 07:41:02 +0000

Designation: Chief – Medical Oncology (Unit I)

Specialty: Oncology,Hematology

Location: Gurgaon

Nationality: Indian

Languages spoken: Hindi,English,Punjabi

Gender: Male

Artemis Hospital, Gurgaon

Profile:

Qualifications
MBBS, MD, DM & PDCR

Post Graduate
MD (Internal Medicine), SMS Hospital, Jaipur
DM (Oncology), AIIMS, New Delhi
Junior Registrar, Tata Memorial Centre, Mumbai
Professional Diploma in Clinical Research

Brief Profile
Dr. Hari Goyal had the privilege to work in best of Cancer Centers of India. He started his career in the field of Oncology at Tata Memorial Centre & did the prestigious course of DM from All India Institute of Medical Sciences, New Delhi.

He is the head of Oncology unit comprising eminent doctors like Dr. Deepak Singla, Dr. Mohit Saxena & Dr. Smita B. Choudhury. The team effort gives an edge & advantage to the patients’ management.

His practice has a major influence of teachings of pioneers in oncology, Dr. S.H. Advani, Dr. Vinod Kochupillai & Dr. Lalit Kumar. He has long associations with experts like Dr. P.K. Julka, Dr. Subodh Pandey, Dr. S. Hukku, Dr. Sudhir Bahadur & Dr. K.K. Pandey.

His yesteryear colleagues are now prominent cancer specialists & are heading the cancer department of big institutions across the country and other part of the globe.

His contribution to oncology is immense & has developed drugs for management of chemotherapy side effects. This development has helped millions of cancer patients since 2004. He was a part of large number of clinical trials of cancer research including one of the FDA audited trial. He has many prestigious awards to his credit which reflect his dedication, in- depth knowledge & collaboration with other departments to cure cancer.

Immunotherapy in cancer is evolving very rapidly and a large number of patients are getting significant improvement in quality of life. Experience of these drugs in patients as well as in pivotal international clinical trials has made him one of the forerunners in the quest to control disease through immunotherapy. In depth knowledge & intent of these molecules is immense & it directs him to select patients who can be benefited or not from immunotherapy. Presently he is running clinical trial on drugs like : DURVALUMAB, TREMELIMUMAB, ATEZOLIZUMAB and others.

His communication, truthful discussions about outcome & energetic attitude is the key to his present success. Consistency, punctuality & empathy are some of his qualities which are admired by his patients & colleagues. A hard worker with a positive attitude towards the sick, he deals with all kinds of cancer. He has a passion for cure & control of cancer which make him an exceptional oncologist. His motto is to provide comprehensive & holistic treatment to each & every cancer patient.

An expert of traditional drugs to recent advances, he is a hope, constant support & a friend of cancer patients & their families. He is adored by one & all. He is a versatile personality & a prolific writer. He is an expert of calligraphy & considered as a motivational guru by hundreds.

MEMBERSHIP
Member to many personal, professional & social organisations.

HONOURS AND REWARDS
• Triveni Ratna Award given by Member of Parliament, Shri Mahabal Mishra
• Unnat Bharat Seva given by Union Minister of Agriculture at Parliament Annexe
• Awards at many local functions across the country.

Clinical Focus
• Holistic approach towards cancer patients.
• Try to give cure, control and care by best possible means.

Procedures
All procedures related to the specialty.

Publications
Over 30 National & international publications.

Recent ongoing trials
1. Clinical research associate in protocol 94CE 32 .Phase III comparative study of combination treatment with TLC D99 liposomal doxorubicin and cyclophosphamide and doxorubicin in metastatic breast cancer.

2. A Multicentric, open label phase III clinical trial to evaluate the safety of filgrastim in cancer patients with grade 3 or 4 chemotherapy induced neutropenia.

3. Organizing secretary, 4th international seminar on psychosocial oncology, new delhi ,april 1999.

4. TZ-01-002: A Randomized, Double-Blind, Multicentre, Parallel Group Study Comparing Two Humanized Monoclonal Antibodies that Target HER2 Receptors in combination with weekly Paclitaxel Administered as First-Line Treatment in Patients with HER2- Positive Metastatic Breast Cancer”.

5. SB3-G31-BC: “A Phase III Randomised, Double-Blind, Parallel Group, Multicentre Study to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity between SB3 (proposed trastuzumab biosimilar) and Herceptin® in Women with Newly Diagnosed HER2 Positive Early or Locally Advanced Breast Cancer in Neoadjuvant Setting”.

6. A multicentre, randomized, open label, two period, two treatment, two way crossover, comparative bioavailability study at Steady state comparing Capecitabine Extended release Capsule 500mg (Intas Pharmaceuticals Ltd, India) to the reference listed drug Xeloda (Capecitabine 500mg ; Roche Pharmaceuticals) in patients of Breast Cancer or Colorectal cancer under fed condition.

7. A Phase III randomized, open- label, Multi-center, global study of MEDI4736 alone or in combination with Tremelimumab versus standard of Care in the treatment of First-line recurrent or Metastatic Squamous Cell Head & neck cancer patients.

8. A multicenter, open label, balanced, randomized, two treatment, three period, three sequence, reference replicate crossover, single dose, oral bioequivalence study of Capecitabine film coated tablets 500mg of Shilpa Medicare Limited, India & Xeloda film coated tablets 500mg (Capecitabine) marketed by Roche Registration limited, 6 Falcon way, Shire park, Welwyn garden city, AL71 TW United Kingdome following single oral dose of 2000mg (4x500mg) in adult human cancer patients under fed conditions.

The post Dr. Hari Goyal – Artemis Hospital appeared first on Pathway International.

Dr. Chandragouda Dodagoudar – BLK Super Speciality Hospital

Pathway International — Fri, 17 May 2019 07:31:51 +0000

Consultant
Medical Oncology

Qualification

MBBS
MD (Medicine)
DNB (Medical Oncology)
ECMO (Europe)

Experience

Presently working as Consultant in Medical Oncology department at BLK Super Speciality Hospital, New Delhi

Previous Experience:

Consultant – Rajiv Gandhi Cancer Hospital, Delhi
Senior Resident – Max Healthcare, New Delhi
Senior Resident – Apollo Hospitals, Bangalore

Awards and Achievements

Best Resident Doctor award at RGCI and RC- Received an award from Honorable Vice President of India
Bharat Jyoti Award from NGO – India International Friendship Society
2nd Prize in Medical Quiz for post graduates at Diamond APICON Medicine Conference Bombay, India

Membership

Delhi Medical Council
Karnataka Medical Council

Publications:

SR. Gadwalkar, S. Bushan, K. Pramod, Chandragouda, PM Kumar, Bilateral Cerebellar Infarction: A rare complication of scorpion sting, J Association Physician India 2006; 54:581-83
Synchronous Embryonal Rhabdomyosarcoma (NOS) of the Midoesophagus and Stomach: J Gastrointest Canc (2012) 43:217-220.
Trichomegaly of Eyelashes after treatment with Erlotinib in Ca Pancreas: International Journal of Trichology / Jan-Mar 2014 /Vol-6 / Issue-1
Carcinomatosis meningitis — A rare site of progression in carcinoma gall bladder” Accepted for approval (Article Ref. No.: 2730/13/J/DGJ) Journal, Indian Academy of Clinical Medicine (JIACM)
Neuroendocrine carunoma of Gall bladder: A series of 19 cases with review of literature: J.Gastrointest (anc 10.1007/512029-015
Small cell carcinoma of the ovary of hypercalcemic type: National journal of medical research: Volume 4│Issue 1│Jan – Mar 2014
Fatal hematogenous relapse of mucinous borderline ovarian tumor of intestinal type. Indian journal of Medical and Paediatric Oncology |2013 Volume : 34 | Issue : 2 | Page : 134-135
Efficacy and safety of intraperitoneal chemotherapy in optimally debulked stage III ovarian cancer in Indian population. Indian journal of Cancer/Nov 2013/Volume 50/Supplement
Neoadjuvant chemotherapy followed by radical surgery as management of Stage IB2-IIIA cervical cancer in Indian population. Indian journal of Cancer/Nov 2013/Volume 50/Supplement
Efficacy and safety profile of gemcitabine and erlotinib combination in advanced Ca pancreas in India. Indian journal of Cancer/Nov 2013/Volume 50/Supplement
Imatinib in chronic myeloid leukemia: Experience in North Indian population. Indian journal of Cancer/Nov 2013/Volume 50/Supplement
Efficacy and toxicity of FOLFOX-4 as second-line chemotherapy in locally advanced unresectable and metastatic carcinoma gall bladder: A prospective observational study. | 2014 ASCO Annual Meeting Abstracts. J Clin Oncol 32, 2014 (suppl; abstr e15101) e carcinoma

The post Dr. Chandragouda Dodagoudar – BLK Super Speciality Hospital appeared first on Pathway International.

Dr. G. K. Jadhav – Apollo Hospitals: New Delhi

Pathway International — Fri, 17 May 2019 07:24:47 +0000

Specialization: Radiation Oncology
Department: Institutes of Cancer
Location: Indraprastha Apollo Hospitals, New Delhi
Experience: Over 27 years
Qualification: MBBS, MD, DMRT, DNB, MNAMS

Fellowships / Memberships

UICC Fellowship
Commonwealth Fellowship to UK
Member of ASTRO (American Society of Therapeutic Radiation Oncology)
Life member AROI (Association of Radiation Oncologists of India)
SNO (Society of NeuroOncology, Canada)

The post Dr. G. K. Jadhav – Apollo Hospitals: New Delhi appeared first on Pathway International.

Dr. Mohamed Zehran Saipillai – Apollo Hospitals: Chennai

Pathway International — Fri, 17 May 2019 07:11:30 +0000

Medical Oncologist
13 Years of experience

Qualification

MBBS, MRCP (UK), FRCR (Clinical Oncology), FRCP (Edin), FRCP (Glasg)

Work Experience

- Dr Zehran completed his MBBS at the Sri Ramachandra Medical College and Research Institute, Chennai in 2003. He then went to the United Kingdom for further education and training where he spent over 13 years.
- He initially trained as a General Physician and was awarded the MRCP (UK) by the Royal College of Physicians and then joined the very sought-after Clinical Oncology Training Programme at The Clatterbridge Cancer Centre NHS Foundation Trust, a reputed tertiary Oncology Centre near Liverpool.
- Dr Zehran spent five years being dual trained in Radiation Oncology and Systemic Treatments (including Chemotherapy, Targeted / Biological Treatments, Hormone Therapy and Immunotherapy). He successfully completed the FRCR examinations ahead of time during his training.
- He was then appointed as a Consultant Clinical Oncologist at The Clatterbridge Cancer Centre where he spent 3 years prior to relocating back to Chennai for family reasons.
- Dr Zehran served as one of the youngest Examiners for the Final FRCR Examinations in Clinical Oncology at the Royal College of Radiologists in London and spent 3 years in that role.

Registration No

71282

Gender

Male

Awards and Achievements

- Examiner for the Final FRCR Examination at The Royal College of Radiologists’ Faculty of Clinical Oncology – 2013 to 2016
- Chief Organiser of The Clatterbridge Cancer Centre Final FRCR Clinical Oncology Mock Exam – 2013 to 2017
- Royal College of Radiologists’ Tutor for the Merseyside Clinical Oncology Training Programme – 2014 to 2016
- Educational and Clinical Supervisor for the Merseyside Clinical Oncology Training Programme – 2013 to 2016

Professional Memberships

- Member of the Royal College of Physicians – UK
- Fellow of the Royal College of Radiologists – faculty of Clinical Oncology – UK
- Fellow of the Royal College of Physicians of Edinburgh – UK
- Fellow of the Royal College of Physicians and Surgeons of Glasgow
- Tamil Nadu Medical Council – Member
- Indian Medical Council – Member

The post Dr. Mohamed Zehran Saipillai – Apollo Hospitals: Chennai appeared first on Pathway International.

Dr. T.P.S. Bhandari – Apollo Hospitals: Hyderabad

Pathway International — Fri, 17 May 2019 07:02:36 +0000

Consultant
Apollo Health City, Hyderabad

Profile

Dr. Trilok Pratap Singh Bhandari is a General Surgeon and Surgical Oncologist in Jubilee Hills, Hyderabad and has an experience of 18 years in these fields. Dr. Trilok Pratap Singh Bhandari practices at Apollo Hospitals in Jubilee Hills, Hyderabad. He completed MBBS from L.P.S Institute of Cardiology, G.S.V.M Medical College, Kanpur in 1991,MS – General Surgery from King Georges Medical College, Lucknow University in 1995 and DNB – General Surgery from Lady Hardinge Medical College, New Delhi in 1995.

Qualification

MBBS; MS (General Surgery); DNB; FIS (Onc); MCh (Surg Onc), Advanced Onco plastic Breast Surgery

Work Experience

- Indo American Hospital, HyderabadCancer Institute, Adayar, MadrasKGMC, Lucknow
- Assistant Professor, Cancer Institute, Adayar, Chennai, 1999 – 2001
- Chief Registrar, KGMC, Lucknow & Resident, Safdarjung Hospital, New Delhi, 1991 – 2001
- Indo American Hospital, Hyderabad, 2001 – 2002
- Sr. Consultant, Surgical Oncology, Apollo Hospitals, Hyderabad, 2002 – Present

Registration No

84486

Services

Lumpectomy

Gender

Male

Research and Publications

- Principal investigator for celtrion trial, performed advanced robotic colorectal surgery
- Initiated and performed first Limp salvage Surgery Program in Andhar pradesh 2004 to date > 200 Limp salvage Surgeries performed successfully.
- Oncoplastic Breast and Reconstructive surgeon

Professional Memberships

- Indian Society of Oncology
- Member Royal College of Surgeons(London)

Special Interest

- Surgical Oncology

The post Dr. T.P.S. Bhandari – Apollo Hospitals: Hyderabad appeared first on Pathway International.

Dr. S.M. Shuaib Zaidi – Apollo Hospitals: New Delhi

Pathway International — Fri, 17 May 2019 06:47:22 +0000

Specialization: Surgical Oncology

Department: Surgical Oncology

Location: Indraprastha Apollo Hospitals, New Delhi

Qualification: MBBS, MS, MCh (Surgical Oncology

Special Expertise

Esophageal cancer, Lung Cancer, Mediastinal Cancer, Breast and gastrointestinal Cancer.

Fellowships / Memberships / Work Experiences

Fellowship in Thotacic oncologic surgery, OITA University,Japan. Fellowship in Robotic Surgery,IRCAD, Strass Bourg, France.Work Experience – Has worked as senior consultant, Onco surgery Rajiv Gandhi Care limited.

Fellowship in Thoracic Oncology Surgery for Oita University Hospital, Japan

Awards and Achievements

Developed a new technique of head & neck surgery (Radical neck dissection) to preserve marginal mandibular nerve to improve the cosmetic outcare of the procedure. This new technique of Radical Neck Dissection was published in journal of surgical oncology in 2007.

The post Dr. S.M. Shuaib Zaidi – Apollo Hospitals: New Delhi appeared first on Pathway International.